Sonova Holding AG Overview
Pro stress-test →Sonova Holding AG is a global leader in innovative hearing care solutions, holding 24% of the global hearing aid market. The Swiss company develops, manufactures, and markets advanced hearing instruments, cochlear implants, wireless communication systems, and audiological care services through leading brands including Phonak, Unitron, Advanced Bionics, and AudioNova.
Strategic Profile
Pro stress-test →Sonova commands a dominant market position through its diversified portfolio spanning hearing aids, cochlear implants, and consumer audio devices, with presence in over 100 countries and approximately 18,000-19,000 employees. The company leverages proprietary AI technology and dual-chip architecture in its latest Phonak Audéo Sphere Infinio platform, establishing technological leadership in addressing speech-in-noise challenges—a critical market need affecting 1 billion people globally.
Competitive Landscape
Pro stress-test →Sonova faces competition from GN Store Nord (ReSound brand), Widex (now GN), Cochlear Limited, and MED-EL in different segments. In hearing aids, Sonova's 24% market share leads the fragmented market. In cochlear implants, competitors Cochlear Limited and MED-EL hold approximately 67% combined market share, with Sonova's Advanced Bionics at 20%. The market is consolidating around technology leaders with AI capabilities and omnichannel distribution.
Industry Context
Sonova Holding AG operates in Hearing Care / Medical Devices / Audiology.
Key facts
Founded: 1947 · Headquarters: Stäfa, Switzerland · Employees: 18000 · Revenue: CHF 3.6B